Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (26)

2024

  1. Reliability of blood eosinophil count in steady-state bronchiectasis

    Pulmonology

2023

  1. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  2. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

  3. Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

    Cancers, Vol. 15, Núm. 4

2022

  1. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

    Haematologica, Vol. 107, Núm. 11, pp. 2675-2684

  2. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes

    Biomedicines, Vol. 10, Núm. 5

  3. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  4. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis

    Journal of Clinical Medicine, Vol. 11, Núm. 14

  5. Incidence, clinical characteristics, risk factors, and outcomes of upper gastrointestinal bleeding in patients with COVID-19 results of the UMC-19-S12

    Journal of Clinical Gastroenterology, Vol. 56, Núm. 1, pp. E38-E46

  6. Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity

    Biomolecules, Vol. 12, Núm. 10

  7. Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

    Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270

  8. Safety and Revisit Related to Discharge the Sixty-one Spanish Emergency Department Medical Centers Without Hospitalization in Patients with COVID-19 Pneumonia. A Prospective Cohort Study UMC-Pneumonia COVID-19

    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, Vol. 74, Núm. 3, pp. 135-146

  9. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study

    Biomedicines, Vol. 10, Núm. 2

2021

  1. A case-control analysis of stroke in COVID-19 patients: Results of unusual manifestations of COVID-19–study 11

    Academic Emergency Medicine, Vol. 28, Núm. 11, pp. 1236-1250

  2. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 21-27

  3. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2

    International Journal of Cardiology, Vol. 330, pp. 268-272

  4. Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis

    Clinical Microbiology and Infection, Vol. 27, Núm. 3, pp. 428-434

  5. RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 28-35

2020

  1. Bronchoscopist's perception of the quality of the single-use bronchoscope (Ambu aScope4™) in selected bronchoscopies: a multicenter study in 21 Spanish pulmonology services

    Respiratory Research, Vol. 21, Núm. 1

2019

  1. Comparison of different strategies for short-term death prediction in the infected older patient

    Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 156-164